Recruiting

CLiKX Device

Sponsor:

ClinQure, Inc.

Code:

NCT07625657

Conditions

Otitis Media

Otitis Media Chronic

Otitis Media Effusion

Otitis Media Recurrent

Otitis Media in Children

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Interventions

CLiKX® Tympanostomy Tube Delivery System

Study Details

Brief summary:

This study looks at the safety and performance of the CLiKX device. The device is used to place ear tubes (also called ventilation tubes) in children and adults. These tubes help treat chronic ear fluid (otitis media with effusion) and other conditions where a doctor decides an ear tube is needed.

In this study, surgeons will use the CLiKX device to place an ear tube in the patient's ear. The study will check if the surgeon can place the tube correctly in the right position. The procedure will first be attempted with no anesthesia or with local anesthesia. If needed, the surgeon may then use mild sedation or general anesthesia.

The study will also look at how well patients tolerate the procedure by checking for side affects during the procedure.

Finally, the study will look at how the device affects the procedure and patient safety. Researchers will review how the procedure is performed and will follow patients for up to 30 days after the procedure to continue to check for any side effects..

Conditions

Otitis Media

Otitis Media Chronic

Otitis Media Effusion

Otitis Media Recurrent

Otitis Media in Children

Study ID

NCT07625657

Start date

Jun, 2026

Status verified date

Jul, 2026

Completion date

Aug, 2027

Anticipated

Primary completion date

Jun, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Subject is scheduled to undergo tympanostomy tube insertion.
2. Subject is ≥ 6 months old at the time of informed consent.
3. Subject has an ear canal diameter of ≥ 4 mm.
4. Subject is able and willing to provide informed consent or subject's parent/guardian is able and willing to provide informed consent and subject is able and willing to provide assent as age appropriate (age 7 years to 21 years old).

Exclusion Criteria:

1. Subjects who are pregnant as confirmed by the institution's standard pre- surgery practice.
2. Subjects with known adverse reaction to anesthesia.
3. Subjects with atrophic, dimeric, severely thinned and scarred, severely thickened, severely retracted, atelectatic or perforated tympanic membrane.
4. Subjects with otitis externa.
5. Subjects with active acute otitis media.
6. Subjects with an ear canal diameter < 4 mm.
7. Ear drums that are overly vertical or horizontal
8. Subjects with an anatomy that precludes visualization and access to the tympanic membrane, in the opinion of the investigator.
9. Subjects with any condition that, in the opinion of the investigator, may place the subject at greater risk.
10. Subjects with suspected middle ear tumors or vascular lesions.
11. Subjects diagnosed with acute sensorial hearing loss
12. Subjects with a history of surgery involving the ear drum.
13. Subjects with hemotympanum.
14. Subject is not able or willing to comply with study procedures and follow-up requirements, in the opinion of the investigator.

Study Design

Enrollment

80 participants

Anticipated

Intervention Model

Single group

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Tympanostomy Tube Treatment

Subjects undergoing myringotomy with tympanostomy tube placement

Interventions

CLiKX® Tympanostomy Tube Delivery System

The CLiKX device is an automated, sensor-optimized, partially reusable handheld surgical device used for tympanostomy tube placement. It consists of multiple components assembled before use and disassembled after the procedure. The device includes integrated, pre-programmed software that controls its mechanical actions. The software is locked, cannot be modified by users, and does not perform diagnostic or therapeutic decision-making. Instead, it provides visual cues and applies controlled force to assist the procedure. Compared to manual techniques, the CLiKX device automates key steps, including creating a precise slit incision using regulated force. This approach is designed to reduce operator variability, minimize trauma to the tympanic membrane, and improve accuracy of tube placement. Clinicians retain full control over targeting throughout the procedure.

Primary outcome measure

  • Effectiveness of C-TTDS for tympanostomy tube placement [ Time Frame: At time of procedure (first or second attempt) ]
  • Safety of C-TTDS for tympanostomy tube placement [ Time Frame: At time of procedure (first or second attempt) ]

Central Contacts and Locations

Central contacts

Locations

Advanced ENT and Allergy, PLLC

Recruiting

Louisville, Kentucky, United States, 40220

Contacts

Certified Clinical Research Coordinator

(502) 399-1884ddavis@advancedentandallergy.com

Principal Investigator:

Steven Shotts, MD

More Information

Sponsor

ClinQure, Inc.

Last update posted

Jul 20, 2026

Last verified

Jul, 2026

Keywords

  • otitis media
  • Tympanostomy tube
  • NousQ
  • CLiKX
  • myringotomy

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by ClinQure, Inc. on 2026-07-20.